A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
TURKISH JOURNAL OF HEMATOLOGY, cilt.36, sa.4, ss.230-237, 2019 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 36 Sayı: 4
- Basım Tarihi: 2019
- Doi Numarası: 10.4274/tjh.galenos.2019.2018.0307
- Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.230-237
- Anahtar Kelimeler: Thrombocytopenia, Immune thrombocytopenic, Eltrombopag, LONG-TERM, PURPURA, SAFETY, ADULTS, ITP
- Bursa Uludağ Üniversitesi Adresli: Evet
Özet
Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP).